Shares in MeiraGTx rose after the company said it received positive data in a clinical bridging study of AAV-GAD for the treatment of Parkinson's disease. Shares were up nearly 14% in premarket ...

Norton Neuroscience Institute is the first and only facility in Kentucky to offer MRI-guided high-frequency focused ...

MeiraGTx Holdings (NASDAQ:MGTX) added ~14% in the premarket on Tuesday after the New York-based biotech announced promising ...

Exciting results for MeiraGTx Holdings plc's GAD gene therapy for Parkinson's Disease, with promising phase 1/2 data and ...

BPI sells a huge selection of therapeutic tints and lenses complete with frames or clipons. By filtering out UV and blue ...

The disruption of abnormal activity in the gut microbiome may increase our risk for neurological disease, research suggests.

MALVERN, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical ...

Diamondback Energy Inc. $181.58-9.13-4.79% ...